<p>Dr. Robert Gilman of A.B. PRISMA in Peru proposes to develop a rapid method of evaluating treatment response to tuberculosis and multidrug-resistant TB by measuring exhaled nitric oxide. Preliminary data has shown that patients with MDR-TB exhibit elevated levels of FeNO, and identifying these patients early can lead to alternative treatments to reduce transmission.</p>


Dr. Robert Gilman of A.B. PRISMA in Peru proposes to develop a rapid method of evaluating treatment response to tuberculosis and multidrug-resistant TB by measuring exhaled nitric oxide. Preliminary data has shown that patients with MDR-TB exhibit elevated levels of FeNO, and identifying these patients early can lead to alternative treatments to reduce transmission.

Longitudinal Feno Levels in Active Pulmonary Tuberculosis

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.